Sichuan Hebang Biotechnology Corporation Limited (603077.SS)
CNY 1.69
(0.0%)
CNY 1.69
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 430.66 Million CNY | 0.15% |
| 2022 | 430.02 Million CNY | 308.95% |
| 2021 | 105.15 Million CNY | -59.93% |
| 2020 | 262.4 Million CNY | 16.11% |
| 2019 | 226 Million CNY | -26.62% |
| 2018 | 307.97 Million CNY | -37.69% |
| 2017 | 494.25 Million CNY | -37.89% |
| 2016 | 795.8 Million CNY | -7.87% |
| 2015 | 863.75 Million CNY | -13.78% |
| 2014 | 1 Billion CNY | 24.45% |
| 2013 | 804.99 Million CNY | 8.05% |
| 2012 | 745 Million CNY | -39.08% |
| 2011 | 1.22 Billion CNY | 22.3% |
| 2010 | 1 Billion CNY | -11.11% |
| 2009 | 1.12 Billion CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 650.25 Million CNY | 50.99% |
| 2024 Q2 | 684.65 Million CNY | 5.29% |
| 2024 Q3 | 604.28 Million CNY | -11.74% |
| 2023 Q2 | 398.94 Million CNY | 81.4% |
| 2023 FY | 430.66 Million CNY | 0.15% |
| 2023 Q4 | 430.66 Million CNY | -36.77% |
| 2023 Q3 | 681.11 Million CNY | 70.73% |
| 2023 Q1 | 219.92 Million CNY | -48.86% |
| 2022 Q3 | 236.94 Million CNY | -28.74% |
| 2022 Q2 | 332.49 Million CNY | -22.88% |
| 2022 Q1 | 431.15 Million CNY | 310.02% |
| 2022 FY | 430.02 Million CNY | 308.95% |
| 2022 Q4 | 430.02 Million CNY | 81.49% |
| 2021 FY | 105.15 Million CNY | -59.93% |
| 2021 Q4 | 105.15 Million CNY | 4.64% |
| 2021 Q2 | 242.34 Million CNY | 1.39% |
| 2021 Q3 | 100.48 Million CNY | -58.54% |
| 2021 Q1 | 239.02 Million CNY | -8.91% |
| 2020 Q3 | 364 Million CNY | 70.09% |
| 2020 FY | 262.4 Million CNY | 16.11% |
| 2020 Q1 | 216 Million CNY | -4.42% |
| 2020 Q2 | 214 Million CNY | -0.93% |
| 2020 Q4 | 262.4 Million CNY | -27.91% |
| 2019 Q3 | 357.14 Million CNY | 0.02% |
| 2019 Q2 | 357.08 Million CNY | -0.26% |
| 2019 Q1 | 358.02 Million CNY | 16.25% |
| 2019 FY | 226 Million CNY | -26.62% |
| 2019 Q4 | 226 Million CNY | -36.72% |
| 2018 FY | 307.97 Million CNY | -37.69% |
| 2018 Q4 | 307.97 Million CNY | 0.02% |
| 2018 Q3 | 307.91 Million CNY | 0.02% |
| 2018 Q2 | 307.86 Million CNY | -44.49% |
| 2018 Q1 | 554.57 Million CNY | 12.2% |
| 2017 Q4 | 494.25 Million CNY | -38.02% |
| 2017 FY | 494.25 Million CNY | -37.89% |
| 2017 Q3 | 797.43 Million CNY | 0.07% |
| 2017 Q2 | 796.88 Million CNY | 0.07% |
| 2017 Q1 | 796.34 Million CNY | 0.07% |
| 2016 Q3 | 795.28 Million CNY | 0.07% |
| 2016 Q4 | 795.8 Million CNY | 0.07% |
| 2016 Q1 | 794.25 Million CNY | -8.05% |
| 2016 FY | 795.8 Million CNY | -7.87% |
| 2016 Q2 | 794.76 Million CNY | 0.06% |
| 2015 FY | 863.75 Million CNY | -13.78% |
| 2015 Q1 | 997.29 Million CNY | -0.45% |
| 2015 Q4 | 863.75 Million CNY | -5.42% |
| 2015 Q3 | 913.26 Million CNY | -5.14% |
| 2015 Q2 | 962.77 Million CNY | -3.46% |
| 2014 FY | 1 Billion CNY | 24.45% |
| 2014 Q3 | 665.79 Million CNY | -5.63% |
| 2014 Q4 | 1 Billion CNY | 50.47% |
| 2014 Q2 | 705.52 Million CNY | 42.46% |
| 2014 Q1 | 495.25 Million CNY | -38.48% |
| 2013 Q1 | 430 Million CNY | -42.28% |
| 2013 Q2 | 704.47 Million CNY | 63.83% |
| 2013 Q3 | 804.73 Million CNY | 14.23% |
| 2013 Q4 | 804.99 Million CNY | 0.03% |
| 2013 FY | 804.99 Million CNY | 8.05% |
| 2012 FY | 745 Million CNY | -39.08% |
| 2012 Q4 | 745 Million CNY | -15.34% |
| 2012 Q3 | 880 Million CNY | -3.3% |
| 2012 Q2 | 910 Million CNY | 0.0% |
| 2011 FY | 1.22 Billion CNY | 22.3% |
| 2011 Q4 | 1.22 Billion CNY | 0.0% |
| 2010 FY | 1 Billion CNY | -11.11% |
| 2009 FY | 1.12 Billion CNY | 0.0% |